Every recall we track for Apotex Corp. — 33 in all — plus the complaints and injury reports the public filed about them.
Apotex recalls 37.5mg Paxil CR tablets due to failing 24-month stability tests. This may affect medication safety. Check your prescription bottle for NDC 60505-4379-3.
Apotex recalls Desmopressin Nasal Spray (50 doses) due to defective bottle caps that may dislodge. This could cause the spray to leak or contaminate the product. Consumers should check their bottle's lot number and contact Apotex for details.
Apotex recalls 5mL prescription eye drops (0.2%/0.5%) due to lack of sterility assurance. This could cause infections if used improperly. Check NDC 60505-0589-1 and lots VJ8599 or VL1668.
Apotex recalls Ketorolac eye drops due to potential sterility issues from improper bottle sealing. This may cause infections. Check batch numbers on bottles for affected products.
Apotex recalls 0.2%/0.5% eye drops due to potential sterility issues from improper sealing. Affected lots expire Dec 2025. Stop using if you have these specific sizes.
Apotex recalls 0.2%/0.5% eye drops due to potential contamination. Stop using if you have the specific batch number. No remedy details provided in official notice.
Apotex recalls 10 mg/mL Lacosamide Oral Solution (200mL) due to leaking when stored horizontally. This prescription drug may cause medication exposure risks if the container leaks.
Apotex recalls 0.05% Azelastine HCl eye drops due to potential lack of sterility. This could cause infections if used improperly. Consumers should contact Apotex for details.
Apotex recalls Ketorolac 0.5% eye drops due to lack of sterility assurance. This could cause infections. Check NDC 60505-1003-2, batch TZ1236, exp 11/30/2025.
Apotex recalls Fluticasone Propionate Nasal Spray 50mcg 120 sprays due to potential Burkholderia cepacia contamination. This may pose health risks for users with compromised immune systems.
Apotex recalls 10 mg Paroxetine Hydrochloride Tablets due to failed impurities testing. These tablets could pose health risks if used as directed. Consumers should contact Apotex for details.
Apotex recalls 30mg Paroxetine Hydrochloride tablets (NDC 60505-0084-1, 60505-0084-2, 60505-0084-4) due to impurities. These prescription antidepressants may have unsafe chemical levels that could cause harm.
Apotex recalls nasal spray with glass splinter risk. Foreign particles in pump may cause malfunction. Stop using immediately if affected.
Apotex recalls Brimonidine Tartrate Ophthalmic Solution 0.15% (Rx only) due to cap cracks that may compromise sterility. Affected units have specific NDC/UPC codes and expiration dates. Consumers should contact Apotex for details.
Apotex recalls Timolol Maleate Ophthalmic Solution 0.5% 2.5mL (Rx only) due to stability issues. Product may lose effectiveness over time, but no immediate safety risk.
Apotex recalls 20mg Aripiprazole tablets due to failed dissolution testing at 12 months. This may affect medication effectiveness. Check NDC codes for affected batches.
Apotex recalls Sirolimus Oral Solution (1 mg/mL, 60mL) due to failed dissolution specifications in one lot. This may affect medication effectiveness. Check your product details to see if it's affected.
Apotex recalls 10mg leflunomide tablets (30-count and 1000-count bottles) due to subpotent quality. These prescription drugs may not meet strength specifications.
